Bayer Opens Office In Belgrade

20 April 1997

German chemical and pharmaceutical company Bayer has opened an office inBelgrade, in the Federal Republic of Yugoslavia. There are 10 staff employed at the office, who will concentrate initially on market research and advising industrial users of Bayer's products. The next step will be to add the activities of the firm's health care and agriculture businesses, Bayer said.

After achieving sales in Yugoslavia last year of 11 million Deutschemarks ($6.4 million), Bayer expects turnover to rise to 12 million marks in the current year, and that this figure will have risen to 30 million marks by the year 2000.

The founding company of the Belgrade office is Bayer International in Switzerland. The president of the company, Hans Pestalozzi, emphasized at the opening of the office that Bayer has had good trading relations with customers in Yugoslavia for many years. "It is our aim to build the same market position here as we already hold in the countries of western Europe," he said.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight